Read more
The third edition of
The American Society of Addiction Medicine Handbook of Addiction Medicine provides authoritative, evidence-based guidance on evaluating, treating, and managing patients with substance use disorders. It begins with a clinical perspective on addiction, followed by an overview of treatment modalities and strategies for effective patient engagement. The handbook includes eight detailed chapters on specific drug classes: alcohol, sedatives, opioids, nicotine, stimulants, cannabinoids, hallucinogens, and inhalants, each covering diagnosis, medical complications, and treatment.
Additional chapters address the non-medical use of prescription drugs, anabolic steroids, and athletes. It also covers comprehensive medical care for patients with substance use disorders, including primary care, complications from injection drug use, harm reduction, care of patients receiving opioid agonist treatment, and pain management. Guidance on assessing and treating psychiatric disorders in patients with substance use disorders is provided, along with discussions on the impact on special populations such as adolescents, women, older adults, LGBTQ individuals, and health professionals. The final chapter explores ethical and legal considerations, including the criminalization of drug use, Good Samaritan laws, the Americans with Disabilities Act, substance use during pregnancy, and core clinical ethical principles.
List of contents
- Preface
- 1. Introduction
- Darius A. Rastegar and Michael I. Fingerhood
- 2. Overview of Substance Use Disorder Treatment
- Darius A. Rastegar
- 3. Screening and Brief Intervention
- Michael I. Fingerhood
- 4. Alcohol
- Michael I. Fingerhood and Darius Rastegar
- 5. Sedatives/Hypnotics
- Jordan H. Nahas-Vigon and Michael I. Fingerhood
- 6. Opioids
- Ashish P. Thakrar and Darius A. Rastegar
- 7. Nicotine and Tobacco
- Darius A. Rastegar
- 8. Stimulants
- Ryan Graddy and Darius A. Rastegar
- 9. Cannabinoids
- Jarratt D. Pytell and Darius A. Rastegar
- 10. Hallucinogens and Dissociatives
- Darius A. Rastegar
- 11. Inhalants: Volatile Organic Compounds, Anaesthetics and Nitrites
- Darius A. Rastegar
- 12. Prescription Drugs
- Darius A. Rastegar
- 13. Anabolic Steroids and Athletes
- Michael I. Fingerhood
- 14. Medical Care for Patients with Substance Use Disorders
- Megan Buresh and Darius A. Rastegar
- 15. Psychiatric Co-Occurring Disorders
- Vinay K. Parekh and Kenneth B. Stoller
- 16. Special Populations
- Jessica Ratner and Michael I. Fingerhood
- 17. Ethical and Legal Considerations
- Noelle Martinez and Michael I. Fingerhood
About the author
Darius A. Rastegar is a Professor of Clinical Medicine at Johns Hopkins School of Medicine. He graduated from University of Pennsylvania Medical School and completed his training in internal medicine at Johns Hopkins Bayview Medical Center. He is board certified in Internal Medicine and Addiction Medicine and has had over 25 years of clinical experience treating patients with substance use disorders. He is the medical director of the Addiction Medicine Unit at Johns Hopkins Bayview Medical Center and the Program Director for the Addiction Medicine Fellowship at Johns Hopkins.
Michael I. Fingerhood is a Professor of Medicine and Public Health at Johns Hopkins University, and Chief of the Division of Addiction Medicine within the Johns Hopkins Department of Medicine. He graduated from the Albert Einstein College of Medicine in the Bronx, NY, and completed internal medicine training and a chief resident year at Johns Hopkins Bayview Medical Center. He is board certified in Internal
Medicine and Addiction Medicine and has had over 35 years of clinical experience treating patients with substance use disorders. He chairs the ASAM State of the Art Conference and the ASAM Medical Education Council.
